Citations (32)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
D. C. Evenden, S. C. Brailsford, C. M. Kipps, P. J. Roderick & B. Walsh. (2021) Hybrid simulation modelling for dementia care services planning. Journal of the Operational Research Society 72:9, pages 2147-2159.
Read now
Read now
Articles from other publishers (31)
Xiaoyan Liu, Yan Sun, Xuyan Zhang, Ping Liu, Kan Zhang, Lihua Yu, Yujie Su, Yuan Yuan, Qing Ke & Guoping Peng. (2023) Prevalence and outcomes of rapidly progressive dementia: a retrospective cohort study in a neurologic unit in China. BMC Geriatrics 23:1.
Crossref
Crossref
Jin-Hui Choi, Bon-Hoon Koo, Wan-Seok Seo, Eun-Jin Cheon, Hyung-Mo Sung, Ji Yean Kim, Hyun-Seok Jeong, Younggyo Kim & Hye-Geum Kim. (2023) Characteristics of Cognitive Function Changes and Related Factors in Individuals With Cognitive Impairment During the Pandemic of COVID-19: A Retrospective Chart Review Study. Psychiatry Investigation 20:2, pages 109-119.
Crossref
Crossref
Ping Wang, Peipei Wang, Hengfei Luan, Yong Wu & Ying Chen. (2022) Midazolam alleviates cellular senescence in SH‐SY5Y neuronal cells in Alzheimer's disease. Brain and Behavior 13:1.
Crossref
Crossref
Carl I. Cohen, Barry Reisberg & Robert Yaffee. (2022) Global cognitive trajectory patterns in Alzheimer’s disease. International Psychogeriatrics, pages 1-10.
Crossref
Crossref
Ioanna Katzourou, Ganna Leonenko, Dobril Ivanov, Alun Meggy, Rachel Marshall, Rebecca Sims, Julie Williams, Peter Holmans & Valentina Escott-Price. (2021) Cognitive Decline in Alzheimer’s Disease Is Not Associated with APOE. Journal of Alzheimer's Disease 84:1, pages 141-149.
Crossref
Crossref
Roberto Santangelo, Federica Agosta, Francesco Masi, Edoardo Gioele Spinelli, Giordano Cecchetti, Francesca Caso, Alessandra Mandelli, Rosalinda Cardamone, Alessandra Barbieri, Roberto Furlan, Giuseppe Magnani & Massimo Filippi. (2021) Plasma neurofilament light chain levels and cognitive testing as predictors of fast progression in Alzheimer’s disease. European Journal of Neurology 28:9, pages 2980-2988.
Crossref
Crossref
Luis Agüera-Ortiz. (2021) Looking for navigation charts for the journey through dementia. International Psychogeriatrics 33:8, pages 747-749.
Crossref
Crossref
Jinghuan Gan, Shuai Liu, Hao Wu, Zhichao Chen, Min Fei, Junying Xu, Yuchao Dou, Xiaodan Wang & Yong Ji. (2021) The Impact of the COVID-19 Pandemic on Alzheimer's Disease and Other Dementias. Frontiers in Psychiatry 12.
Crossref
Crossref
David A. Loeffler. (2021) Modifiable, Non-Modifiable, and Clinical Factors Associated with Progression of Alzheimer’s Disease. Journal of Alzheimer's Disease 80:1, pages 1-27.
Crossref
Crossref
I. Katzourou, P. Holmans, J. Williams & V. Escott-Price. (2020) P.320 Assessing disease progression in Alzheimer's disease. European Neuropsychopharmacology 31, pages S61-S62.
Crossref
Crossref
Christin Nance, Aaron Ritter, Justin B. Miller, Brittany Lapin & Sarah J. Banks. (2019) The Pathology of Rapid Cognitive Decline in Clinically Diagnosed Alzheimer’s Disease. Journal of Alzheimer's Disease 70:4, pages 983-993.
Crossref
Crossref
Karen Stanley, Tim Whitfield, Karoline Kuchenbaecker, Oliver Sanders, Tim Stevens & Zuzana Walker. (2019) Rate of Cognitive Decline in Alzheimer’s Disease Stratified by Age. Journal of Alzheimer's Disease 69:4, pages 1153-1160.
Crossref
Crossref
Xiaoyi Lin, Benhong Xu, Zaijun Zhang, Ying Yang, Gongping Liu, Feiqi Zhu, Xiaohu Ren, Jianjun Liu, Shupeng Li, Xianfeng Huang & Xifei Yang. (2019) Proteomic analysis reveals the potential neuroprotective effects of tetramethylpyrazine dimer in neuro2a/APPswe cells. RSC Advances 9:33, pages 18776-18784.
Crossref
Crossref
Rosalyn Hithersay, Carla M. Startin, Sarah Hamburg, Kin Y. Mok, John Hardy, Elizabeth M. C. Fisher, Victor L. J. Tybulewicz, Dean Nizetic & André Strydom. (2019) Association of Dementia With Mortality Among Adults With Down Syndrome Older Than 35 Years. JAMA Neurology 76:2, pages 152.
Crossref
Crossref
Maja Jazvinšćak Jembrek, Katy Newberg & Goran Šimić. 2019. Pathology, Prevention and Therapeutics of Neurodegenerative Disease. Pathology, Prevention and Therapeutics of Neurodegenerative Disease
39
48
.
Ya-Nan Song, Ping Wang, Wei Xu, Jie-Qiong Li, Xi-Peng Cao, Jin-Tai Yu & Lan Tan. (2018) Risk Factors of Rapid Cognitive Decline in Alzheimer’s Disease and Mild Cognitive Impairment: A Systematic Review and Meta-Analysis. Journal of Alzheimer's Disease 66:2, pages 497-515.
Crossref
Crossref
Maja Jazvinšćak Jembrek, Neda Slade, Patrick R. Hof & Goran Šimić. (2018) The interactions of p53 with tau and Aß as potential therapeutic targets for Alzheimer’s disease. Progress in Neurobiology 168, pages 104-127.
Crossref
Crossref
Miriam L. Haaksma, Amaia Calderón-Larrañaga, Marcel G.M. Olde Rikkert, René J.F. Melis & Jeannie-Marie S. Leoutsakos. (2018) Cognitive and functional progression in Alzheimer disease: A prediction model of latent classes. International Journal of Geriatric Psychiatry 33:8, pages 1057-1064.
Crossref
Crossref
Jason T. Slyer, Ella Archibald, Fernea Moyo & Marie Truglio-Londrigan. (2018) Advance care planning and anticipatory decision making in patients with Alzheimer disease. The Nurse Practitioner 43:6, pages 23-31.
Crossref
Crossref
Alba Di Pardo & Vittorio Maglione. (2018) Sphingolipid Metabolism: A New Therapeutic Opportunity for Brain Degenerative Disorders. Frontiers in Neuroscience 12.
Crossref
Crossref
Rannveig Sakshaug Eldholm, Maria Lage Barca, Karin Persson, Anne-Brita Knapskog, Hege Kersten, Knut Engedal, Geir Selbæk, Anne Brækhus, Eva Skovlund & Ingvild Saltvedt. (2018) Progression of Alzheimer’s Disease: A Longitudinal Study in Norwegian Memory Clinics. Journal of Alzheimer's Disease 61:3, pages 1221-1232.
Crossref
Crossref
Achille E. Tchalla, Jean-Pierre Clément, Isabelle Saulnier, Betty Beaumatin, Florent Lachal, Caroline Gayot, Anaïs Bosetti, Iléana Desormais, Anaïck Perrochon, Pierre-Marie Preux, Philippe Couratier & Thierry Dantoine. (2018) Predictors of Rapid Cognitive Decline in Patients with Mild-to-Moderate Alzheimer Disease: A Prospective Cohort Study with 12-Month Follow-Up Performed in Memory Clinics. Dementia and Geriatric Cognitive Disorders 45:1-2, pages 56-65.
Crossref
Crossref
Peter Franz. (2017) Kognitive Störung mit zerebellärem Syndrom. NeuroTransmitter 28:9, pages 46-55.
Crossref
Crossref
Jianping Jia, Serge Gauthier, Sarah Pallotta, Yong Ji, Wenshi Wei, Shifu Xiao, Dantao Peng, Qihao Guo, Liyong Wu, Shengdi Chen, Weihong Kuang, Junjian Zhang, Cuibai Wei & Yi Tang. (2017) Consensus‐based recommendations for the management of rapid cognitive decline due to Alzheimer's disease. Alzheimer's & Dementia 13:5, pages 592-597.
Crossref
Crossref
Marije R. Benedictus, Annebet E. Leeuwis, Maja A.A. Binnewijzend, Joost P.A. Kuijer, Philip Scheltens, Frederik Barkhof, Wiesje M. van der Flier & Niels D. Prins. (2016) Lower cerebral blood flow is associated with faster cognitive decline in Alzheimer’s disease. European Radiology 27:3, pages 1169-1175.
Crossref
Crossref
Maowen Ba, Xiaofeng Li, Kok Pin Ng, Tharick A. Pascoal, Sulantha Mathotaarachchi, Pedro Rosa-Neto & Serge Gauthier. (2017) The prevalence and biomarkers’ characteristic of rapidly progressive Alzheimer's disease from the Alzheimer's Disease Neuroimaging Initiative database. Alzheimer's & Dementia: Translational Research & Clinical Interventions 3:1, pages 107-113.
Crossref
Crossref
Dantao Peng, Zhihong Shi, Jun Xu, Lu Shen, Shifu Xiao, Nan Zhang, Yi Li, Jinsong Jiao, Yan-Jiang Wang, Shuai Liu, Meilin Zhang, Meng Wang, Shuling Liu, Yuying Zhou, Xiao Zhang, Xiao-hua Gu, Ce-ce Yang, Yu Wang, Bin Jiao, Beisha Tang, Jinhuan Wang, Tao Yu & Yong Ji. (2016) Demographic and clinical characteristics related to cognitive decline in Alzheimer disease in China. Medicine 95:26, pages e3727.
Crossref
Crossref
Helen Hochstetler, Paula T. Trzepacz, Shufang Wang, Peng Yu, Michael Case, David B. Henley, Elisabeth Degenhardt, Jeannie-Marie Leoutsakos & Constantine G. Lyketsos. (2016) Empirically Defining Trajectories of Late-Life Cognitive and Functional Decline. Journal of Alzheimer's Disease 50:1, pages 271-282.
Crossref
Crossref
Rui Yang, Qingjun Wang, Fang Li, Jian Li & Xuewen Liu. (2015) Edaravone injection ameliorates cognitive deficits in rat model of Alzheimer’s disease. Neurological Sciences 36:11, pages 2067-2072.
Crossref
Crossref
Maja Jazvinšćak Jembrek, Patrick R. Hof & Goran Šimić. (2015)
Ceramides in Alzheimer’s Disease: Key Mediators of Neuronal Apoptosis Induced by Oxidative Stress and A
β
Accumulation
. Oxidative Medicine and Cellular Longevity 2015, pages 1-17.
Crossref
Crossref
Karen Stanley & Zuzana Walker. (2014) Do patients with young onset Alzheimer's disease deteriorate faster than those with late onset Alzheimer's disease? A review of the literature. International Psychogeriatrics 26:12, pages 1945-1953.
Crossref
Crossref